These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3985871)

  • 41. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fowl cholera: gel diffusion precipitin test for serotyping Pasteruella multocida from avian species.
    Heddleston KL; Gallagher JE; Rebers PA
    Avian Dis; 1972; 16(4):925-36. PubMed ID: 4628021
    [No Abstract]   [Full Text] [Related]  

  • 43. Pasteurella multocida: antibody-mediated resistance to virulent challenge exposure in vaccinated turkeys.
    Nathanson RM; Hofstad MS; Jeska EL
    Am J Vet Res; 1980 Aug; 41(8):1285-7. PubMed ID: 7447124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Residues of oxytetracycline and its 4'-epimer in edible tissues from turkeys.
    Capolongo F; Santi A; Tomasi L; Anfossi P; Missagia M; Montesissa C
    J AOAC Int; 2002; 85(1):8-14. PubMed ID: 11878622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of oxytetracycline into ocular tissues and tears of calves.
    George LW; Smith JA; Kaswan R
    J Vet Pharmacol Ther; 1985 Mar; 8(1):47-54. PubMed ID: 3989900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of attenuated live Pasteurella multocida vaccine given in the drinking water every two weeks to an injected oil-base bacterin administered to turkeys.
    Bierer BW; Scott WF
    Poult Sci; 1969 Mar; 48(2):520-3. PubMed ID: 5389868
    [No Abstract]   [Full Text] [Related]  

  • 47. Cross-protection studies with Pasteurella multocida bacterins prepared from bacteria propagated in iron-depleted medium.
    Glisson JR; Contreras MD; Cheng IH; Wang C
    Avian Dis; 1993; 37(4):1074-9. PubMed ID: 8141736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue concentrations of a long-acting oxytetracycline formulation after intramuscular administration in cattle.
    Landoni MF; Errecalde JO
    Rev Sci Tech; 1992 Sep; 11(3):909-15. PubMed ID: 1472735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma bioavailability of 2 long-acting oxytetracycline formulations in the pig.
    Archimbault P; Navetat H; Vidal R; Douin MJ; Mignot A
    Vet Res; 1994; 25(4):399-404. PubMed ID: 8087147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity of capsular antigens of Pasteurella multocida in turkeys.
    Kodama H; Matsumoto M; Snow LM
    Am J Vet Res; 1981 Oct; 42(10):1838-41. PubMed ID: 7325454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy and harmlessness of inactivated Pasteurella multocida vaccines following subcutaneous, oral and intranasal administration in mice].
    Baljer G; Chorherr S; Mayr A
    Zentralbl Veterinarmed B; 1982 May; 29(4):275-83. PubMed ID: 7124198
    [No Abstract]   [Full Text] [Related]  

  • 52. Depletion of the residues of colistin and amoxicillin in turkeys following simultaneous subcutaneous administration.
    Tomasi L; Giovannetti L; Rondolotti A; Della Rocca G; Stracciari GL
    Vet Res Commun; 1996; 20(2):175-82. PubMed ID: 8711898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of a subcutaneously administered, ultraviolet light-killed Pasteurella haemolytica A1-containing vaccine against transthoracic challenge exposure in goats.
    Purdy CW; Straus DC; Sutherland RJ; Ayres JR
    Am J Vet Res; 1996 Aug; 57(8):1168-74. PubMed ID: 8836369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
    Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C
    Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The protective effect conferred by Pasteurella multocida bacterin administered intranasally.
    Wichmann RW; Stoner JH
    Avian Dis; 1974; 18(4):631-3. PubMed ID: 4433308
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys.
    Hopkins BA; Olson LD
    Avian Dis; 1997; 41(2):317-25. PubMed ID: 9201394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative kinetics of oxytetracycline and oxyglucocycline cotent in tissues of the ENT organs].
    Pluzhnikov MS; Gevorkian EA
    Antibiotiki; 1976 Oct; 21(10):933-6. PubMed ID: 999245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lesions resulting from attempted Shwartzman reaction in turkey poults inoculated with Pasteurella multocida lipopolysaccharide.
    Mendes S; Carmichael KP; Nunnally JC; Glisson JR; Cheng IH; Harmon BG
    Avian Dis; 1994; 38(4):790-6. PubMed ID: 7702512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum pharmacokinetics of oxytetracycline in sheep and calves and tissue residues in sheep following a single intramuscular injection of a long-acting preparation.
    Craigmill AL; Holland RE; Robinson D; Wetzlich S; Arndt T
    J Vet Pharmacol Ther; 2000 Dec; 23(6):345-52. PubMed ID: 11168911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxytetracycline concentrations in healthy and diseased calves.
    Ames TR; Larson VL; Stowe CM
    Am J Vet Res; 1983 Jul; 44(7):1354-7. PubMed ID: 6881673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.